KME-2780

N/A

Report date: 2024/12/20 14:21:04

Base Information

Drug NameKME-2780
Drug Alias NameKME-2780
ClassificationOther
Mechanisms of ActionInterleukin-1 receptor-associated kinase 1 inhibitorsInterleukin-1 receptor-associated kinase 4 inhibitors
TargetsInterleukin-1 receptor-associated kinase 1Interleukin-1 receptor-associated kinase 4
Therapy Area/IndicationsMyelodysplastic SyndromesLeukemia, Myeloid, Acute
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesKurome Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesKurome Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsMyelodysplastic SyndromesLeukemia, Myeloid, Acute
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A